Amedeo Smart

Free Medical Literature Service

 

Amedeo

Ischemic Heart Disease
  Free Subscription

Articles published in
Mayo Clin Proc
    January 2026
  1. XIA X, Chen S, Tian X, Xu Q, et al
    Hypothetical Interventions on Multiple Cardiometabolic Risk Factors for Cardiovascular Disease Prevention: A Target Trial Emulation.
    Mayo Clin Proc. 2026 Jan 23:S0025-6196(25)00611.
    >> Share

  2. COLLINGS PJ, Wang M, Chen Z, Shi Q, et al
    Cardiorespiratory Fitness, Genetic Risk, and Incident Atherosclerotic Cardiovascular Events: A Prospective Cohort Study.
    Mayo Clin Proc. 2026 Jan 21:S0025-6196(25)00477.
    >> Share

  3. PRASAD VK, Ogbonnaya C, Oh H, Atkin A, et al
    Association of Body Fatness With Hypertension, Dyslipidemia, and Myocardial Infarction in a Multinational Pooled Cohort.
    Mayo Clin Proc. 2026 Jan 5:S0025-6196(25)00573.
    >> Share

    December 2025
  4. ABDALLA HM, Bacon A, VanDolah H, Dreher L, et al
    Cannabidiol in Cardiovascular Disease: A Review of Current Evidence and Future Directions.
    Mayo Clin Proc. 2025 Dec 29:S0025-6196(25)00566.
    >> Share

  5. ZALAQUETT Z, Shukla N, Hajj J, El Helou MC, et al
    Cardiovascular Toxicity of Fluoropyrimidines: What We Know.
    Mayo Clin Proc. 2025 Dec 4:S0025-6196(25)00476.
    >> Share


  6. Corrigendum to 'The Impact of Lipid-Lowering Combination Therapy of Statins and Ezetimibe vs Statin Monotherapy on the Reduction of Cardiovascular Outcomes: A Meta-Analysis' [Mayo Clinic Proceedings, Article in Press, https://doi.org/10.1016/j.mayocp.
    Mayo Clin Proc. 2025;100:2279.
    >> Share

    October 2025
  7. MOON IT, Park YK, Yi HJ, Chun HJ, et al
    Long-term Outcomes of Hypertension and Antihypertensive Drugs in Healthy Young Adults: A Nationwide Population-Based Prospective Cohort Study in Korea.
    Mayo Clin Proc. 2025;100:1758-1770.
    >> Share

    September 2025
  8. ZAHID S, Peng AW, Razavi AC, Yao Z, et al
    Does the New Clinical Obesity Definition Address the Obesity Paradox in Cardiovascular Health?
    Mayo Clin Proc. 2025 Sep 30:S0025-6196(25)00397.
    >> Share

    August 2025
  9. HALL ME, Khan LA, Javaid SS
    Cardiovascular Risk Factor Variability: Why Consistency Matters.
    Mayo Clin Proc. 2025;100:1285-1287.
    >> Share

  10. KUNUTSOR SK, Laukkanen JA
    Lessons From a Contemporary Cohort: Acute Kidney Injury After Percutaneous Coronary Intervention and the Need for Renewed Prevention Strategies.
    Mayo Clin Proc. 2025;100:1278-1280.
    >> Share

    July 2025
  11. PATEL N, Gaonkar M, Pampana A, Dhaliwal JS, et al
    Cardiovascular Health and Outcomes in Carriers With Genetic Variants of Hypertrophic Cardiomyopathy.
    Mayo Clin Proc. 2025 Jul 23:S0025-6196(24)00694.
    >> Share

  12. KATTAH AG, Coutinho TD, Vermunt J, Vaughan LE, et al
    Blood Pressure Thresholds for Hypertension in Pregnancy and Future Cardiovascular Risk.
    Mayo Clin Proc. 2025 Jul 23:S0025-6196(25)00241.
    >> Share

  13. SALEH AK, Bowman SE, Scheinuk JE, Josey G, et al
    Impact of Social Determinants of Health on Atherosclerotic Cardiovascular Disease in Transgender Individuals.
    Mayo Clin Proc. 2025 Jul 7:S0025-6196(25)00028.
    >> Share

  14. TAVOLINEJAD H, Chirinos JA
    Use of Plasma Proteomics to Interrogate the Biologic Footprint of Ischemic Heart Disease in Heart Failure.
    Mayo Clin Proc. 2025;100:1095-1097.
    >> Share

  15. BAE JH, Choi J, Kim NH, Kim SG, et al
    In Reply: Ischemic Stroke, Type 2 Diabetes, Glucose-Lowering Drugs, and Cardiovascular Events.
    Mayo Clin Proc. 2025;100:1255-1257.
    >> Share

  16. FAUCHIER L, Lochon L, Guglieri M
    Ischemic Stroke, Type 2 Diabetes, Glucose-Lowering Drugs, and Cardiovascular Events.
    Mayo Clin Proc. 2025;100:1254-1255.
    >> Share

    June 2025
  17. NAGARAJA V, Rihal CS, Reeder G, Nath KA, et al
    Impact of Renal Function and Acute Kidney Injury on Long-term Outcomes After Percutaneous Coronary Intervention.
    Mayo Clin Proc. 2025 Jun 7:S0025-6196(25)00086.
    >> Share

  18. ERGI DG, Crestanello JA, Holst K, Villavicencio Theoduloz MA, et al
    Obesity-Conduit Selection and Effect on Outcomes of Coronary Artery Bypass Grafting.
    Mayo Clin Proc. 2025 Jun 3:S0025-6196(25)00160.
    >> Share

    May 2025
  19. SINGH M, Valgimigli M
    Pretreatment With P2Y(12) Inhibitors in Contemporary Practice: Where Do We Stand?
    Mayo Clin Proc. 2025;100:868-881.
    >> Share

  20. ROZANSKI A, Gransar H, Miller RJH, Han D, et al
    Comparative Predictors of Mortality Risk in Contemporary Patients Referred for Stress Myocardial Perfusion Imaging.
    Mayo Clin Proc. 2025;100:828-839.
    >> Share

    April 2025
  21. PEREYRA PIETRI M, Farina JM, Scalia IG, Roarke M, et al
    Characterization of Cardiovascular Events and Prognosis in Immune Checkpoint Inhibitor-Related Myocarditis.
    Mayo Clin Proc. 2025 Apr 9:S0025-6196(24)00693.
    >> Share

    March 2025
  22. KUKU KO, Hashemian M, Joo J, Shearer JJ, et al
    Proteomic Profile of Ischemic Heart Disease in Heart Failure: A Community Study.
    Mayo Clin Proc. 2025 Mar 31:S0025-6196(24)00692.
    >> Share

  23. BANACH M, Jaiswal V, Ang SP, Sawhney A, et al
    Impact of Lipid-Lowering Combination Therapy With Statins and Ezetimibe vs Statin Monotherapy on the Reduction of Cardiovascular Outcomes: A Meta-analysis.
    Mayo Clin Proc. 2025 Mar 20:S0025-6196(25)00075.
    >> Share

  24. TIAN X, Zhang Y, Chen S, Xia X, et al
    Blood Pressure Time in Target Range Within 24 Hours and Cardiovascular Diseases and Mortality: Perspectives From a Real-World Cohort Study.
    Mayo Clin Proc. 2025 Mar 4:S0025-6196(24)00412.
    >> Share

    February 2025
  25. SCHNOHR P, O'Keefe JH, Lavie CJ, Suetta C, et al
    Comparison of Muscle Strength and Cardiorespiratory Fitness in Relation to Cardiovascular and All-Cause Mortality: The Copenhagen City Heart Study.
    Mayo Clin Proc. 2025 Feb 5:S0025-6196(24)00413.
    >> Share

  26. INGRAHAM BS, Valgimigli M, Angiolillo DJ, Capodanno D, et al
    Relevance of High Bleeding Risk and Postdischarge Bleeding in Patients Undergoing Percutaneous Coronary Intervention.
    Mayo Clin Proc. 2025;100:304-331.
    >> Share

    January 2025
  27. ZHEUTLIN AR, Stulberg EL, Chaitoff A, Harris BRE, et al
    County-Level Social Determinants of Health and Coronary Heart Disease: An Ecological Analysis of US Adults.
    Mayo Clin Proc. 2025 Jan 13:S0025-6196(24)00490.
    >> Share

  28. BAE JH, Choi J, Kim NH, Kim SG, et al
    Cardiovascular Outcomes With Antidiabetic Drugs in People With Type 2 Diabetes and a Prior Stroke.
    Mayo Clin Proc. 2025 Jan 11:S0025-6196(24)00415.
    >> Share

  29. SHETTY NS, Gaonkar M, Patel N, Vekariya N, et al
    PREVENT and Pooled Cohort Equations in Atherosclerotic Cardiovascular Disease Risk Prediction: A Post Hoc Analysis of SPRINT.
    Mayo Clin Proc. 2025 Jan 4:S0025-6196(24)00426.
    >> Share

    December 2024
  30. KIDANE RD, Ruddy KJ, Lin G, Sandhu NP, et al
    Cardiovascular Health Considerations for Primary Care Physicians Treating Breast Cancer Survivors.
    Mayo Clin Proc. 2024 Dec 4:S0025-6196(24)00414.
    >> Share

    November 2024
  31. INGRAHAM BS, Huxley SB, Lane CM, Gulati R, et al
    Genotype-Guided P2Y(12) Inhibitor Monotherapy Within 7 Days of Percutaneous Coronary Intervention in High Bleeding Risk Patients: The CHAMP Trial - A Pilot Study and Safety Assessment.
    Mayo Clin Proc. 2024 Nov 26:S0025-6196(24)00307.
    >> Share

  32. ISMAYL M, Raphael CE, Prasad A, Chareonthaitawee P, et al
    Agreement of Doppler Flow Velocity Reserve With PET Flow Reserve in Patients With Angina Without Obstructive Coronary Arteries.
    Mayo Clin Proc. 2024 Nov 12:S0025-6196(24)00403.
    >> Share

    October 2024
  33. TIMSANS J, Kerola AM, Rantalaiho VM, Hakkarainen KN, et al
    "Metabolic" Type of Hyperuricemia Increases Mortality Mainly by Leading to Premature Death From Cardiovascular Disease.
    Mayo Clin Proc. 2024 Oct 9:S0025-6196(24)00355.
    >> Share

  34. MORGENTALER A, Dhindsa S, Dobs AS, Hackett G, et al
    Androgen Society Position Paper on Cardiovascular Risk With Testosterone Therapy.
    Mayo Clin Proc. 2024 Oct 9:S0025-6196(24)00408.
    >> Share

    September 2024
  35. DENBY KJ, Zmaili M, Datta S, Das T, et al
    Developments and Controversies in Invasive Diagnosis of Coronary Microvascular Dysfunction in Angina With Nonobstructive Coronary Arteries.
    Mayo Clin Proc. 2024;99:1469-1481.
    >> Share

    August 2024
  36. WANG Z, VanderPluym JH, Halker Singh RB, Alsibai RA, et al
    Safety of Triptans in Patients Who Have or Are at High Risk for Cardiovascular Disease: A Target Trial Emulation.
    Mayo Clin Proc. 2024 Aug 29:S0025-6196(24)00164.
    >> Share

  37. WANG J, Ye Y, Chen X, Hu X, et al
    Trends in Statin Use for the Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults by Age, 1999-2020.
    Mayo Clin Proc. 2024 Aug 9:S0025-6196(24)00305.
    >> Share

  38. SHETTY NS, Gaonkar M, Pampana A, Patel N, et al
    Genetic Risk and Coronary Artery Calcium in Personalizing Antihypertensive Treatment: A Pooled Cohort Analysis.
    Mayo Clin Proc. 2024 Aug 7:S0025-6196(24)00027.
    >> Share

  39. KOHLER TS, Kloner RA, Rosen RC, Burnett AL, et al
    The Princeton IV Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease.
    Mayo Clin Proc. 2024 Aug 7:S0025-6196(24)00276.
    >> Share

  40. LIN DS, Huang KC, Lin TT, Lee JK, et al
    Effects of Colchicine on Major Adverse Limb and Cardiovascular Events in Patients With Peripheral Artery Disease.
    Mayo Clin Proc. 2024 Aug 6:S0025-6196(24)00249.
    >> Share

    July 2024
  41. WRIGHT RS, Ray KK, Landmesser U, Koenig W, et al
    Effects of Inclisiran in Patients With Atherosclerotic Cardiovascular Disease: A Pooled Analysis of the ORION-10 and ORION-11 Randomized Trials.
    Mayo Clin Proc. 2024 Jul 5:S0025-6196(24)00167.
    >> Share

  42. VALLABHAJOSYULA S, Abbott JD, Kapur NK
    The Need to Define High-Dose Pharmacological Circulatory Support in Cardiogenic Shock.
    Mayo Clin Proc. 2024;99:1035-1037.
    >> Share

  43. ABDELAZIZ A, Hafez A, Abdelaziz M, Atta K, et al
    Empagliflozin and Cardiovascular Outcomes Across Urine Albumin to Creatinine Ratio Categories: A Systematic Review and Meta-analysis.
    Mayo Clin Proc. 2024;99:1188-1191.
    >> Share

    June 2024
  44. TAN NY, Asirvatham SJ
    Preoperative Atrial Fibrillation in Coronary Artery Bypass Grafting Patients: Evidence and Gaps.
    Mayo Clin Proc. 2024;99:864-866.
    >> Share

  45. KUNUTSOR SK, Laukkanen JA
    A U-Shaped Challenge: Addressing Cardiovascular Outcomes in Cancer Patients With Body Mass Index Changes.
    Mayo Clin Proc. 2024;99:861-863.
    >> Share

    May 2024
  46. HAWKINS-VAN DER CINGEL G, Walsh SB, Eckardt KU, Knauf F, et al
    Oxalate Metabolism: From Kidney Stones to Cardiovascular Disease.
    Mayo Clin Proc. 2024 May 16:S0025-6196(24)00090.
    >> Share

  47. BHATTA DN, Bommer W
    Trends in California Cardiovascular Disease Mortality: Sex-Race/Ethnicity Disparity and Income Inequality.
    Mayo Clin Proc. 2024 May 13:S0025-6196(24)00104.
    >> Share

  48. UENO K, Kaneko H, Suzuki Y, Okada A, et al
    Change in Body Mass Index and Cardiovascular Outcomes in Patients With Cancer.
    Mayo Clin Proc. 2024 May 4:S0025-6196(24)00087.
    >> Share

    April 2024
  49. TALMOR-BARKAN Y, Yu J, Yacovzada NS, Pravda NS, et al
    Trimethylamine-N-Oxide and Related Metabolites: Assessing Cardiovascular Risk in the Dallas Heart Study.
    Mayo Clin Proc. 2024 Apr 26:S0025-6196(24)00028.
    >> Share

  50. DABROWSKI EJ, Kurasz A, Pasierski M, Pannone L, et al
    Surgical Coronary Revascularization in Patients With Underlying Atrial Fibrillation: State-of-the-Art Review.
    Mayo Clin Proc. 2024 Apr 24:S0025-6196(23)00606.
    >> Share

  51. SPARKS JR, Wang X, Lavie CJ, Zhang J, et al
    Cardiorespiratory Fitness as a Predictor of Non-Cardiovascular Disease and Non-Cancer Mortality in Men.
    Mayo Clin Proc. 2024 Apr 24:S0025-6196(23)00599.
    >> Share

  52. BAINS S, Giudicessi JR, Odening KE, Ackerman MJ, et al
    State of Gene Therapy for Monogenic Cardiovascular Diseases.
    Mayo Clin Proc. 2024;99:610-629.
    >> Share

    March 2024
  53. KNOTT JD, Ola O, De Michieli L, Akula A, et al
    High Baseline High-Sensitivity Cardiac Troponin T Concentrations and Risk of Index Acute Myocardial Infarction.
    Mayo Clin Proc. 2024 Mar 15:S0025-6196(24)00026.
    >> Share

  54. MOSHKOVITZ Y, Orenstein L, Olmer L, Laufer K, et al
    Emulated Trial for Discharge Prescription of Guideline-Directed Medical Therapy and 15-Year Survival After Coronary Artery Bypass Graft Surgery.
    Mayo Clin Proc. 2024 Mar 6:S0025-6196(23)00341.
    >> Share

  55. SHARMA S, Johnson E, Goswami R
    Congenital Absence of Right Coronary Artery.
    Mayo Clin Proc. 2024 Mar 6:S0025-6196(23)00480.
    >> Share

  56. SOROOSH G, Dardari Z, Howard-Claudio C, Lutsey P, et al
    Older Adults' Perceptions of Their Risk and Its Correlation With Coronary Atherosclerosis Burden.
    Mayo Clin Proc. 2024;99:508-510.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016